Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.10.0.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 04, 2018
Nov. 14, 2017
Jun. 24, 2016
Dec. 20, 2013
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Mr. Andrew I. Sealfon [Member]                
Officer compensation $ 325,000              
Mr. Andrew I. Sealfon [Member] | Lease Agreement [Member] | Aircraft [Member]                
Lease payments         $ 1,292 $ 3,876 $ 9,045 $ 13,128
Mr. Mark Pastreich [Member] | Lease Agreement [Member] | Building [Member]                
Monthly lease payments   $ 12,088     11,042 11,042    
Lease payments         33,126 33,126 99,378 99,378
Property taxes paid         12,431 12,862 37,863 37,447
Clinical Research & Support Services Consulting Agreement [Member] | Dr. Mark Baker [Member]                
Amortization of deferred compensation cost         0 0 0 7,000
Clinical Research & Support Services Consulting Agreement [Member] | FREEDOM60 Syringe Infusion System [Member] | Dr. Mark Baker [Member]                
Number of shares issued upon agreement       420,000        
Share price (in dollars per share)       $ 0.20        
Agreement term       3 years        
Consulting Agreement [Member] | Mr. Cyril Narishkin (Consultant) [Member]                
Monthly payment for agreement     $ 16,000          
Officer compensation         $ 0 $ 0 $ 0 $ 16,000